The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer.
 
Zahi Ibrahim Mitri
Consulting or Advisory Role - Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology
 
Jacqueline Vuky
Consulting or Advisory Role - Agendia; Eisai; Genomic Health; Merck
Research Funding - Celldex (Inst); Innocrin Pharma (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Kathleen A. Kemmer
No Relationships to Disclose
 
Michael A. Savin
Honoraria - North American Center for Continuing Medical Education
 
Swapnil Parmar
No Relationships to Disclose
 
Annette Kolodzie Kolodzie
No Relationships to Disclose
 
Brett Johnson
No Relationships to Disclose
 
Rochelle Williams-Belizaire
No Relationships to Disclose
 
Joe W. Gray
Leadership - Convergent Genomics; PDX Pharmacy
Stock and Other Ownership Interests - Abbott Diagnostics; AbbVie; Agilent; Alphabet; Altaba; Amazon; American Airlines; Amgen; ANI Pharmaceuticals; Apple; AT&T; Becton Dickinson; Berkshire Hathaway; Boston Scientific; Cameco; Chevron; Cisco Systems; Cisco Systems; Clorox Company; ConocoPhillips; Devon Energy; Exxon Mobil; Facebook; First Solar; Freeport McMoRan; General Electric; Gilead Sciences; Google; Heineken; Hewlett-Packard; IBM; Intel; Ions Pharmaceuticals; Jet Blue Airlines; Johnson & Johnson; Medtronic; Microsoft; Navidea; OncoMed; Pepsico; Philips Healthcare; Procter & Gamble; Southwest Airlines; Stryker; SunPower; Swiss Helvetia Fund; The Walt Disney Company; Unilever; Walgreens Boots Alliance; Wells Fargo; Yum! Brands; Zimmer BioMet
Consulting or Advisory Role - Center for Causal Discovery; Colorado School of Mines; MJ Murdock Charitable Trust; New Leaf Venture; Radiation Effects Research Foundation; Susan G. Komen for the Cure; University of Minnesota; University of New Mexico Comprehensive Cancer Center
Research Funding - Danaher; Micron; PDX Pharmacy; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Abbott; Cepheid
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; ImmunoMET; SignalChem; Spindletop Ventures; Tarveda Therapeutics
Honoraria - AstraZeneca; Celgene; ImmunoMET; Nuevolution; PDX Pharmacy; Symphogen; Tarveda Therapeutics; Tesaro
Consulting or Advisory Role - AstraZeneca; Critical Outcome Technologies; ImmunoMET; PDX Pharmacy; SignalChem; Symphogen; Takeda/Millennium; Tarveda Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; ImmunoMET; Ions Pharmaceuticals; Karus Therapeutics; NanoString Technologies; Ovarian Cancer Research Foundation; Pfizer; Prospect Creek Foundation; Tarveda Therapeutics
Patents, Royalties, Other Intellectual Property - DSP technology patent with Nanostring; HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Chrysalis Biomedical Advisors; ImmunoMET; Michigan Primary Care Consortium; Pfizer; Symphogen